Clinical Study

Individualized Treatment For Nasopharyngeal Cancer Based On The Patient’S Dna

Posted Date: Oct 2, 2014

  • Investigator: Kevin Redmond
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

This study is being done to see how people with your type of cancer respond to different types or levels of chemotherapy, based on a specific viral marker in their blood. This viral marker is called the Epstein Barr virus, (EBV). A more individualized approach to treating your type of cancer might be found using this blood marker.


To Be Eligible For This Study, Patients Must Have Nasopharyngeal Cancer (In The Head And Neck Region Of Your Body) That Has Not Spread To Other Parts Of Your Body


Head & Neck, Nrg-Hn001, Nasopharyngeal Carcinoma, Cancer

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant